Clinical Scorecard: Toward Better Management of Charles Bonnet Syndrome
At a Glance
| Category | Detail |
|---|---|
| Condition | Charles Bonnet Syndrome (CBS) |
| Key Mechanisms | Release or de-afferentation due to reduced visual input leading to heightened excitability in the visual cortex. |
| Target Population | Patients with visual impairment experiencing visual hallucinations. |
| Care Setting | Routine eye care services. |
Key Highlights
- CBS affects approximately 1 in 5 patients attending low vision services.
- Patients often do not disclose hallucinations without direct inquiry.
- Education about CBS can significantly reduce patient distress.
- Behavioral and environmental strategies can help manage symptoms.
- Referral for psychological support is recommended for persistent distress.
Guideline-Based Recommendations
Diagnosis
- Ask patients directly about hallucinations using normalizing language.
Management
- Explore details of hallucinations: onset, frequency, duration, triggers, and emotional impact.
- Implement behavioral and environmental strategies to reduce symptoms.
Monitoring & Follow-up
- Assess the emotional impact of hallucinations and patient distress levels.
Risks
- Risk of CBS increases with more severe vision loss, but can occur with preserved acuity.
Patient & Prescribing Data
Individuals with visual impairment experiencing CBS.
Education is crucial; around 70% of patients report minimal distress after reassurance.
Clinical Best Practices
- Embed a stigma-reducing CBS pathway into consultations.
- Use simple language to normalize discussions about hallucinations.
- Encourage the use of relaxation techniques and environmental adjustments.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
